Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1,966.16% | -26.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 871.49% | -24.30% | |||
| Operating Income | -846.94% | 24.30% | |||
| Income Before Tax | -2,460.24% | 1,909.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,459.99% | 1,909.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 242.16% | 1,872.53% | |||
| EBIT | -846.94% | 24.30% | |||
| EBITDA | -862.37% | 20.34% | |||
| EPS Basic | 216.71% | 1,872.43% | |||
| Normalized Basic EPS | -768.33% | 10.96% | |||
| EPS Diluted | 216.71% | 1,872.43% | |||
| Normalized Diluted EPS | -768.33% | 10.96% | |||
| Average Basic Shares Outstanding | 21.79% | 0.00% | |||
| Average Diluted Shares Outstanding | 21.79% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||